DIDS

CAT: 0804-HY-121693Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-121693Size:1 Each
Selected
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
DIDS is a dual inhibitor of ABCA1 and VDAC1. DIDS also inhibits RAD51, inhibiting RAD51-mediated homologous pairing and strand exchange reactions. DIDS inhibits anion exchange and binding to red blood cell membranes, inhibits the activation of caspase-3 and -9, and can be used in cancer research[1][2][3][4].
CAS Number
[53005-05-3]
Product Name Alternative
MDL101114ZA (free base)
UNSPSC
12352005
Hazard Statement
H315-H319-H335
Target
RAD51; VDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Membrane Transporter/Ion Channel
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dids.html
Solubility
10 mM in DMSO
Smiles
O=S(C1=CC(N=C=S)=CC=C1/C=C/C2=CC=C(C=C2S(=O)(O)=O)N=C=S)(O)=O
Molecular Formula
C16H10N2O6S4
Molecular Weight
454.52
Precautions
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P362+P364-P403+P233-P405-P501
References & Citations
[1]Ishida T, et, al. DIDS, a chemical compound that inhibits RAD51-mediated homologous pairing and strand exchange. Nucleic Acids Res. 2009 Jun;37 (10) :3367-76.|[2]Lepke S, et, al. A study of the relationship between inhibition of anion exchange and binding to the red blood cell membrane of 4,4'-diisothiocyano stilbene-2,2'-disulfonic acid (DIDS) and its dihydro derivative (H2DIDS) . J Membr Biol. 1976 Oct 20;29 (1-2) :147-77.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
VDAC1
Citation 01
Cell Death Discov. 2023 Jul 8;9 (1) :234.|Adv Sci (Weinh) . 2021 Nov;8 (21) :e2101936.|Autophagy. 2021 Nov;17 (11) :3592-3606.|Biochem Biophys Res Commun. 2021 Jun 30:560:52-58.|bioRxiv. 2023 Jul 3.|bioRxiv. 2024 July 10.|Br J Pharmacol. 2025 Aug;182 (16) :3923-3951.|Cancer Sci. 2020 Nov;111 (11) :4288-4302.|Cell Death Dis. 2024 Nov 9;15 (11) :811.|CNS Neurosci Ther. 2025 Apr;31 (4) :e70410.|FEBS Open Bio. 2022 Feb;12 (2) :516-522.|Front Pharmacol. 2023 Jun 26:14:1191692. |J Cell Mol Med. 2021 Jun;25 (11) :5238-5249.|Life Sci. 2020 Oct 15;259:118390.|Phytomedicine. 2024 May 28:130:155785.|Proc Natl Acad Sci U S A. 2025 Oct 7;122 (40) :e2502841122.|Sci Total Environ. 2024 Jun 30:946:174246.|SSRN. 2023 Nov 14.|Virulence. 2025 Dec;16 (1) :2490208.

Popular Products